Some physicians might be unaware with the regional/distant metastasis-totally free survival edge explained inside of a subsequent publication, in which the regional and distant metastatic failure amount was reduced by practically 50 percent from the focal boost arm [2]. Added ongoing trials could also corroborate the FLAME results, encouraging adoption. https://antoniov110kwh4.madmouseblog.com/profile